By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous metabolic agents > Lumasiran > Lumasiran Dosage
Miscellaneous metabolic agents
https://themeditary.com/dosage-information/lumasiran-dosage-8628.html

Lumasiran Dosage

Drug Detail:Lumasiran (Lumasiran [ loo-ma-sir-an ])

Drug Class: Miscellaneous metabolic agents

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Primary Hyperoxaluria

At least 20 kg:

  • Loading dose: 3 mg/kg subcutaneously once a month for 3 doses
  • Maintenance dose: 3 mg/kg subcutaneously every 3 months (quarterly)

Use: For the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels

Usual Pediatric Dose for Primary Hyperoxaluria

Less than 10 kg:

  • Loading dose: 6 mg/kg subcutaneously once a month for 3 doses
  • Maintenance dose: 3 mg/kg subcutaneously once a month

10 to less than 20 kg:
  • Loading dose: 6 mg/kg subcutaneously once a month for 3 doses
  • Maintenance dose: 6 mg/kg subcutaneously every 3 months (quarterly)

At least 20 kg:
  • Loading dose: 3 mg/kg subcutaneously once a month for 3 doses
  • Maintenance dose: 3 mg/kg subcutaneously every 3 months (quarterly)

Use: For the treatment of PH1 to lower urinary oxalate levels

Renal Dose Adjustments

Estimated GFR at least 30 mL/min/1.73 m2: No adjustment recommended.
Estimated GFR less than 30 mL/min/1.73 m2: Data not available

Liver Dose Adjustments

Mild or moderate liver dysfunction: No adjustment recommended.
Severe liver dysfunction: Data not available

Comments:

  • Mild liver dysfunction: Total bilirubin greater than the upper limit of normal (ULN) to 1.5 times the ULN (1.5 x ULN) or AST greater than ULN
  • Moderate liver dysfunction: Total bilirubin greater than 1.5 to 3 x ULN with any AST
  • Severe liver dysfunction: Total bilirubin greater than 3 x ULN with any AST

Precautions

CONTRAINDICATIONS: None

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • For subcutaneous use
  • Divide injection volumes greater than 1.5 mL equally into multiple syringes.
  • Use a sterile 0.3-mL syringe for volumes less than 0.3 mL.
  • Administer subcutaneous injection into the abdomen, thigh, or the side/back of the upper arms; rotate injection sites; do not inject into scar tissue or reddened/inflamed/swollen areas.
  • If injecting into the abdomen, avoid the area around the navel.
  • If more than 1 injection is needed for a single dose, ensure injection sites are at least 2 centimeters apart.
  • If dose is delayed/missed, administer as soon as possible; resume prescribed monthly or quarterly dosing from most recently administered dose.

Storage requirements:
  • Store at 2C to 25C (36F to 77F).
  • Store in original container until ready for use.

General:
  • Dosing is based on actual body weight.
  • This drug should be administered by a healthcare professional.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by